Scarica l'app Stockscreener
10.90
5.63%
-0.65
Dopo l'orario di chiusura:
11.11
0.21
+1.93%
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
Chart overlay techniques for tracking MBX Biosciences Inc.July 2025 Analyst Calls & High Accuracy Swing Entry Alerts - Newser
Signal strength of MBX Biosciences Inc. stock in tech scannersRate Cut & Weekly High Potential Stock Alerts - Newser
Automated trading signals detected on MBX Biosciences Inc.2025 Earnings Surprises & Daily Technical Stock Forecast Reports - Newser
What recovery options are there for MBX Biosciences Inc.Earnings Beat & Daily Market Momentum Tracking - Newser
How to use Fibonacci retracement on MBX Biosciences Inc.Trade Entry Summary & Scalable Portfolio Growth Ideas - Newser
Should you hold or exit MBX Biosciences Inc. nowWeekly Gains Summary & Smart Money Movement Alerts - Newser
MBX Biosciences Inc. Recovery Potential Based on Technical ToolsOil Prices & Reliable Momentum Entry Alerts - beatles.ru
Will MBX Biosciences Inc. Bounce From 52 Week LowQuarterly Investment Review & Consistent Profit Trading Strategies - beatles.ru
What’s the recovery path for long term holders of MBX Biosciences Inc.July 2025 Trends & Low Risk Growth Stock Ideas - Newser
Backtesting results for MBX Biosciences Inc. trading strategies2025 Pullback Review & Stock Portfolio Risk Management - Newser
Published on: 2025-09-08 04:32:19 - Newser
What earnings revisions data tells us about MBX Biosciences Inc.Portfolio Value Summary & Short-Term Swing Trade Alerts - Newser
Is this a good reentry point in MBX Biosciences Inc.Weekly Gains Report & Real-Time Volume Analysis - Newser
Risk adjusted return profile for MBX Biosciences Inc. analyzedStock Surge & Reliable Momentum Entry Alerts - Newser
MBX Biosciences (NASDAQ:MBX) Stock Rating Lowered by Wall Street Zen - MarketBeat
What technical models suggest about MBX Biosciences Inc.’s comeback2025 Analyst Calls & Safe Entry Point Identification - Newser
What high frequency data says about MBX Biosciences Inc.Trade Volume Report & High Conviction Trade Alerts - Newser
Volume spikes in MBX Biosciences Inc. stock – what they meanMarket Risk Report & Community Trade Idea Sharing Platform - Newser
MBX Biosciences Inc. stock prediction for this weekLong Setup & Real-Time Volume Spike Alerts - Newser
How hedge fund analytics apply to MBX Biosciences Inc. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Forecasting MBX Biosciences Inc. price range with options dataWeekly Trade Summary & Community Consensus Picks - Newser
MBX Biosciences Inc. stock retracement – recovery analysisJuly 2025 Gainers & Pattern Based Trade Signal System - Newser
Is MBX Biosciences Inc. still worth holding after the dipEarnings Recap Summary & Short-Term High Return Strategies - Newser
Using economic indicators to assess MBX Biosciences Inc. potentialEarnings Summary Report & Weekly Stock Performance Updates - Newser
What’s the beta of MBX Biosciences Inc. stockJuly 2025 WrapUp & Community Shared Stock Ideas - خودرو بانک
Is MBX Biosciences Inc. exposed to political risk2025 Dividend Review & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Is MBX Biosciences Inc. a strong growth stock2025 Sector Review & Verified Stock Trade Ideas - خودرو بانک
What’s the fair value of MBX Biosciences Inc. stockEarnings Recap Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
MBX Biosciences begins phase 1 trial of obesity treatment candidate By Investing.com - Investing.com Canada
What is MBX Biosciences Inc. s debt to equity ratioWeekly Trade Report & AI Forecasted Entry/Exit Points - خودرو بانک
Technical analysis overview for MBX Biosciences Inc. stockTrade Volume Report & Risk Controlled Daily Plans - Newser
What is MBX Biosciences Inc.’s book value per share2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - خودرو بانک
MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity - MarketScreener
MBX Biosciences Begins Phase 1 Trial for Obesity Drug - TipRanks
MBX Biosciences begins phase 1 trial of obesity treatment candidate - Investing.com
First-Ever Monthly GLP-1/GIP Obesity Drug Enters Clinical Trials: MBX Biosciences' Novel Treatment Begins Testing - Stock Titan
Identifying reversal signals in MBX Biosciences Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Is MBX Biosciences Inc. forming a reversal patternPortfolio Gains Summary & Reliable Price Breakout Alerts - Newser
How to escape a deep drawdown in MBX Biosciences Inc.2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Momentum Traders Eye MBX Biosciences Inc. for Quick BouncePortfolio Profit Report & Risk Managed Trade Strategies - beatles.ru
Will MBX Biosciences Inc. rebound enough to break evenJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Charles Schwab Investment Management Inc. Purchases 1,235 Shares of MBX Biosciences, Inc. $MBX - Defense World
Does MBX Biosciences Inc. meet Warren Buffett’s criteria2025 Macro Impact & Short-Term High Return Ideas - خودرو بانک
How does MBX Biosciences Inc. compare to its peersLayoff News & AI Driven Stock Price Forecasts - خودرو بانک
Smart tools for monitoring MBX Biosciences Inc.’s price action2025 Market Trends & Detailed Earnings Play Strategies - Newser
0.75%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):